Sort
82,697 grants matching “vaccine development”
Noroviruses and Epidemic Gastroenteritis
$1,292,197Kim Y. Green · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Development of strategies to achieve immunoprotection against Cryptosporidiosis
$1,292,121Saul R Tzipori · University Of Maryland Baltimore · U19 · FY2014 · AI
AIDS CLINICAL TRIALS UNIT
$1,291,903Andrew Zolopa · Stanford University · U01 · FY2006 · AI
Lymphocyte Dynamics
$1,291,699William Paul · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Comparative Modeling to Inform Cervical Cancer Control Policies
$1,291,168Jane Jooyun Kim · Harvard School Of Public Health · U01 · FY2016 · CA
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses
$1,290,899Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses
$1,290,899Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Task C03: MAINTENANCE, DEVELOPMENT AND PRODUCTION OF SCHISTOSOMIASIS PARASITES, AND REAGENTS
$1,290,806Margaret Kane · Biomedical Research Institute · N01 · FY2019 · AI
Human Respiratory Syncytial Virus Biology And Vaccine Development
$1,290,643Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Structural studies of native-like SOSIP trimers
$1,290,523Ian A Wilson · Weill Medical Coll Of Cornell Univ · P01 · FY2015 · AI
Comparative Modeling to Inform Cervical Cancer Control Policies
$1,290,361Jane Jooyun Kim · Harvard School Of Public Health · U01 · FY2021 · CA
Dendritic cells heterogeneity and function
$1,290,048Roxane Tussiwand · National Institute Of Dental & Craniofacial Research · ZIA · FY2021 · DE
SPORE in Skin Cancer
$1,289,947Wistar Institute · P50 · FY2002 · CA
Structural Approaches to HIV-1 Immunogen Design and BNAb Analysis
$1,289,810Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2019 · AI
Structural Approaches to HIV-1 Immunogen Design and BNAb Analysis
$1,289,808Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2020 · AI
Integrated genomics research in parasitic tropical diseases
$1,289,587Joana Carneiro Da Silva · University Of Maryland Baltimore · U19 · FY2015 · AI
Molecular approaches to understand vector-host and vector-pathogen interactions
$1,289,543Jesus Valenzuela · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Vectored HIV Immunotherapy via in vivo B cell editing
$1,289,517David T Curiel · Washington University · R01 · FY2024 · AI
Development Of New Approaches To Vaccines Against TBEV and West Nile Virus
$1,289,116Alexander Pletnev · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Evaluating Modes of Influenza Transmission using a Randomized Controlled Trial (EMIT-2-RCT)
$1,289,028Donald K Milton · Univ Of Maryland, College Park · U19 · FY2023 · AI
PEDIATRIC AIDS CLINICAL TRIALS UNIT
$1,288,316Children'S Memorial Hospital (Chicago) · U01 · FY2000 · AI
A Vaccine for Schistosomiasis, "SchistoShield"
$1,288,089Darrick Albert Carter · Pai Life Sciences, Inc. · R44 · FY2018 · AI
Stellenbosch University Clinical Trials Unit (SUN-CTU)
$1,287,739Mark Fredric Cotton · Stellenbosch University · UM1 · FY2017 · AI
Structural Studies of Pattern Recognition Receptors
$1,287,582Tsan Xiao · Niaid Extramural Activities · Z01 · FY2007 · AI
Transition to Human Phase 1b Trials: Nonclinical Studies of an Anti-METH mAb
$1,287,478Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2014 · DA